| |
| |
|
| Insider
Information: |
Heffernan Michael Thomas |
| Relationship: |
|
| City: |
Cary |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
115,623 |
|
|
Indirect Shares
|
163,043 |
|
|
| Direct
Value |
$2,063,018 |
|
|
|
Indirect Value
|
$5,287,484 |
|
|
| Total
Shares |
278,666 |
|
|
| Total
Value |
$7,350,503 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
45,508 |
2016-04-05 |
163,043 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2017-06-09 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2021-06-02 |
48,586 |
2018-12-12 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2019-05-09 |
6,351 |
2019-05-09 |
0 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2022-10-03 |
15,178 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,707 |
207,069 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-08-09 |
4 |
D |
$11.24 |
$53,716 |
D/D |
(4,779) |
126,623 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-02-10 |
4 |
D |
$21.62 |
$107,278 |
D/D |
(4,962) |
101,050 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-23 |
4 |
AS |
$23.00 |
$114,747 |
D/D |
(4,989) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-23 |
4 |
OE |
$16.15 |
$80,572 |
D/D |
4,989 |
33,012 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
D |
$7.50 |
$41,303 |
D/D |
(5,507) |
19,370 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-05-10 |
4 |
AS |
$26.00 |
$186,100 |
D/D |
(7,100) |
538,693 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,486 |
7,486 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2024-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,693 |
45,508 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-02-08 |
4 |
D |
$14.39 |
$112,976 |
D/D |
(7,851) |
277,362 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4/A |
D |
$7.50 |
$72,743 |
D/D |
(9,699) |
15,178 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
37,815 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,941 |
13,988 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2017-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-08-11 |
4 |
AS |
$19.13 |
$250,048 |
D/D |
(13,071) |
54,122 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2016-04-05 |
4 |
OE |
$0.48 |
$33,905 |
D/D |
13,604 |
387,048 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
21,186 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
34,886 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
48,586 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
28,023 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-23 |
4 |
AS |
$25.01 |
$410,364 |
D/D |
(16,408) |
518,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2016-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,135 |
373,444 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-05-20 |
4 |
D |
$22.05 |
$411,233 |
D/D |
(18,650) |
63,146 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-05-13 |
4 |
AS |
$20.92 |
$416,421 |
D/D |
(19,254) |
81,796 |
0 |
% |
|
82 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
